These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6629278)

  • 1. [Principles for the use of digitalis in elderly patients].
    Rietbrock N; Woodcock BG
    Fortschr Med; 1983 Sep; 101(33):1491-2. PubMed ID: 6629278
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of coronary insufficiency with digitalis. 1. Principles of therapy].
    Grosse-Brockhoff F
    Fortschr Med; 1981 Apr; 99(16):573-5. PubMed ID: 7227950
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction of digitalis glycoside intoxication by rational dosing procedures.
    Clayton BD
    Am J Hosp Pharm; 1974 Sep; 31(9):855-65. PubMed ID: 4418578
    [No Abstract]   [Full Text] [Related]  

  • 4. Digitalis therapy in renal failure with special regard to digitoxin.
    Vöhringer HF; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):175-84. PubMed ID: 7021432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Do we use digitalis properly in the management of elderly patients suffering from the signs of chronic heart failure?].
    Erdei F; Vendrey R; Dani G; Kovács E; Márk L; Katona A
    Orv Hetil; 2006 Oct; 147(41):1993-6. PubMed ID: 17120690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Digitalis therapy in the aged].
    Follath F
    Fortschr Med; 1982 Aug; 100(31-32):1431-4. PubMed ID: 6182078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prediction of pharmacokinetic behaviour of digitalis glycosides in patients under intensive care conditions and in patients undergoing anaesthesia and operation (author's transl)].
    Rietbrock I
    Anaesthesist; 1978 Apr; 27(4):151-62. PubMed ID: 350085
    [No Abstract]   [Full Text] [Related]  

  • 8. [Positive ionotropic substances (digitoxin and digoxin). Principles and rules of use].
    Gelu M; Caron J; Libersa C
    Rev Prat; 1999 May; 49(9):1017-23. PubMed ID: 11865453
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparing the toxicity of digoxin and digitoxin in a geriatric population: should an old drug be rediscovered?
    Roever C; Ferrante J; Gonzalez EC; Pal N; Roetzheim RG
    South Med J; 2000 Feb; 93(2):199-202. PubMed ID: 10701788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Digoxon or digitoxin in patients with terminal kidney insufficiency in the dialysis stage?].
    Risler T; Peters U; Grabensee B; Fritsch WP; Hausamen TU; Grosse-Brockhoff F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1662-4. PubMed ID: 611905
    [No Abstract]   [Full Text] [Related]  

  • 11. [Problems of glycoside therapy in kidney insufficiency and uremia].
    Rupp M; Brass H; Glöckler D
    Med Welt; 1981 Jan; 32(4):115-22. PubMed ID: 7207142
    [No Abstract]   [Full Text] [Related]  

  • 12. [Incidence of side effects in digitalis therapy].
    Flasch H
    Fortschr Med; 1982 Oct; 100(38):1743-8. PubMed ID: 7141373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gitoformate and digitoxin as alternatives to kidney-dependent glycosides in the therapy of cardiac insufficiency].
    Rietbrock N; Woodcock BG; Hrazdil U
    Arzneimittelforschung; 1984; 34(8):915-7. PubMed ID: 6541927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical aspects of monitoring cardiac drugs in the blood.
    Wieland H
    Wien Klin Wochenschr Suppl; 1992; 191():48-51. PubMed ID: 1509754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Digitoxin, digoxin. Principles and rules of use, dosage].
    Lechat P
    Rev Prat; 1994 Jun; 44(12):1695-9. PubMed ID: 7939249
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determinants of plasma digoxin and digitoxin concentrations in elderly patients. A multivariate analysis].
    Koenig W; Rietbrock N; Woodcock BG; Lehmacher W
    Klin Wochenschr; 1987 Nov; 65(22):1073-80. PubMed ID: 3695294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Positive inotropic substances (digitoxin, digoxin). Principles and rules of use].
    Haïat R
    Rev Prat; 1997 Oct; 47(15):1723-7. PubMed ID: 9406521
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiac glycosides: indications, selection and dosage].
    Kuhlmann J
    Med Klin; 1982 Jan; 77(3):18-22. PubMed ID: 7057727
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug safety associated with the change of digitalis drug in Norway].
    Haga C; Opdal MS; Tuv SS; Zahl PH; Stenberg-Nilsen H
    Tidsskr Nor Laegeforen; 2016 Nov; 136(20):1714-1718. PubMed ID: 27830905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digitalis: facts and fallacies, use and potential abuse.
    Carlson M; Nelson W
    J Kans Med Soc; 1981 Jul; 82(7):355-8, 371. PubMed ID: 7252308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.